According to the previous statistics, the prevalence of VHL mutation is also confirmed by The Cancer Genome Atlas (TCGA) cohort, where the main percentage (52.3%) of ccRCC-mutated genes is represented by the VHL mutation group [14]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.